Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tirzepatide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07245771
What this trial is testing

Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity

Who this might be right for
Obesity &Amp; Overweight
Ikaria Bioscience Pty Ltd 104
Not applicableNot Yet RecruitingNCT07492563
What this trial is testing

Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay

Who this might be right for
ObesityType 2 Diabetes MellitusOverweight With Comorbidities
LABORATORIOS INDUFAR 300
Post-approval studies (Phase 4)Looking for participantsNCT07777575
What this trial is testing

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

Who this might be right for
Obesity (BMI>30)
Technical University of Munich 150
Early research (Phase 1)Looking for participantsNCT07559500
What this trial is testing

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

Who this might be right for
Alcohol Use Disorder (AUD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 176
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07676331
What this trial is testing

Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

Who this might be right for
Hormone-receptor-positive Breast CancerEarly Breast Cancer
Universitaire Ziekenhuizen KU Leuven 168
Testing effectiveness (Phase 2)Looking for participantsNCT06727331
What this trial is testing

Study of Tirzepatide for Recovery and Alcohol Use Management

Who this might be right for
Alcohol Use Disorder (AUD)
Brigham and Women's Hospital 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07483801
What this trial is testing

DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies

Who this might be right for
Cardiovascular Diseases
Cambridge University Hospitals NHS Foundation Trust 112
Post-approval studies (Phase 4)Not Yet RecruitingNCT07027969
What this trial is testing

Metabolic Surgery for Atrial Fibrillation Elimination

Who this might be right for
Atrial FibrillationObesity and Obesity-related Medical Conditions
Ali Aminian 100
Testing effectiveness (Phase 2)Study completedNCT04166773
What this trial is testing

Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Eli Lilly and Company 190
Not applicableStudy completedNCT07203677
What this trial is testing

Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)

Who this might be right for
Type2 Diabetes MellitusAtherosclerotic Cardiovascular Disease
Brigham and Women's Hospital 49,065
Not applicableNot Yet RecruitingNCT07504172
What this trial is testing

Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity

Who this might be right for
Overweight , ObesityObesity (Disorder)
Radboud University Medical Center 1,700
Large-scale testing (Phase 3)Study completedNCT06588296
What this trial is testing

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

Who this might be right for
Psoriatic ArthritisObesity
Eli Lilly and Company 279
Post-approval studies (Phase 4)Active Not RecruitingNCT06864026
What this trial is testing

Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Who this might be right for
Psoriatic ArthritisOverweight or Obesity
Eli Lilly and Company 200
Large-scale testing (Phase 3)Study completedNCT06131437
What this trial is testing

A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight

Who this might be right for
Obesity
Novo Nordisk A/S 809
Testing effectiveness (Phase 2)WithdrawnNCT06901349
What this trial is testing

Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT03131687
What this trial is testing

Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 318
Early research (Phase 1)Study completedNCT06297616
What this trial is testing

LY3841136 in Japanese Participants With Obesity or Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 128
Post-approval studies (Phase 4)Looking for participantsNCT07326111
What this trial is testing

A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese

Who this might be right for
Polycystic Ovary Syndrome (PCOS)Obesity & Overweight
University of Bonn 198
Not applicableNot Yet RecruitingNCT07787936
What this trial is testing

GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

Who this might be right for
Heart Failure With Preserved Ejection FractionObesityDiastolic Heart Failure+2 more
Miedziowe Centrum Zdrowia SA 150
Large-scale testing (Phase 3)Active Not RecruitingNCT06075667
What this trial is testing

Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweight
Eli Lilly and Company 160
Next Page